{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:29Z","timestamp":1783075889385,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1MH084886"],"award-info":[{"award-number":["RO1MH084886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-114989"],"award-info":[{"award-number":["MOP-114989"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-97946"],"award-info":[{"award-number":["MOP-97946"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.schres.2015.02.020","type":"journal-article","created":{"date-parts":[[2015,3,7]],"date-time":"2015-03-07T23:15:57Z","timestamp":1425770157000},"page":"263-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dopamine D2\/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia\u2014A [11C]-raclopride PET study"],"prefix":"10.1016","volume":"164","author":[{"given":"Shinichiro","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caravaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ku","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanna","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2015.02.020_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"6","key":"10.1016\/j.schres.2015.02.020_bb0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neubiorev.2006.06.005","article-title":"The correlative triad among aging, dopamine, and cognition: current status and future prospects","volume":"30","author":"Backman","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2015.02.020_bb0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.02.020_bb0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00004714-199908000-00007","article-title":"Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics","volume":"19","author":"Caligiuri","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2015.02.020_bb0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/hbm.20392","article-title":"Brain region binding of the D2\/3 agonist [11C]-(+)-PHNO and the D2\/3 antagonist [11C]raclopride in healthy humans","volume":"29","author":"Graff-Guerrero","year":"2008","journal-title":"Hum. Brain Mapp."},{"issue":"3","key":"10.1016\/j.schres.2015.02.020_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S1461145709990642","article-title":"Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925","volume":"13","author":"Graff-Guerrero","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2015.02.020_bb0025","series-title":"American College of Neuropsychopharmacology Annual Meeting, Phoenix, U.S.","article-title":"Should antipsychotic dose be decreased in older patients with schizophrenia?\u2014lessons from a longitudinal clinical PET study","author":"Graff-Guerrero","year":"2014"},{"issue":"4","key":"10.1016\/j.schres.2015.02.020_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nimg.1997.0303","article-title":"Parametric imaging of ligand-receptor binding in PET using a simplified reference region model","volume":"6","author":"Gunn","year":"1997","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.schres.2015.02.020_bb0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2015.02.020_bb0050","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/schbul\/sbt043","article-title":"Treating older adults with schizophrenia: challenges and opportunities","volume":"39","author":"Jeste","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2015.02.020_bb0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/schbul\/sbr026","article-title":"Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia","volume":"37","author":"Jeste","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2015.02.020_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"3 Pt 1","key":"10.1016\/j.schres.2015.02.020_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.schres.2015.02.020_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"9","key":"10.1016\/j.schres.2015.02.020_bb0075","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00004647-200109000-00002","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum","volume":"21","author":"Mawlawi","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.schres.2015.02.020_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","article-title":"Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale","volume":"41","author":"Miller","year":"1992","journal-title":"Psychiatry Res."},{"issue":"8","key":"10.1016\/j.schres.2015.02.020_bb0085","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1176\/appi.ajp.162.8.1473","article-title":"PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation","volume":"162","author":"Nader","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.02.020_bb0090","unstructured":"Nakajima, S., Caravaggio, F., Boileau, I., Jun Ku, C., Plitman, E., Gerretsen, P., Wilson, A., Houle, S., Mamo, D., C., Graff-Guerrero, A., In submission. Lack of age-dependent decrease in dopamine D3 receptor availability: A [11C]-(+)-PHNO and [11C]-raclopride positron emission tomography study (in submission)."},{"issue":"3","key":"10.1016\/j.schres.2015.02.020_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/hup.470070302","article-title":"PET analysis of central [11 C]raclopride binding in healthy young adults and schizophrenic patients\u2014reliability and age effects","volume":"7","author":"Nordstr\u00f6m","year":"1992","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2015.02.020_bb0100","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"Suppl. 20","key":"10.1016\/j.schres.2015.02.020_bb0105","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2015.02.020_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"1","key":"10.1016\/j.schres.2015.02.020_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1118\/1.598130","article-title":"Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures","volume":"24","author":"Studholme","year":"1997","journal-title":"Med. Phys."},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.02.020_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pscychresns.2006.05.009","article-title":"Dopamine D2 receptor binding in drug-naive patients with schizophrenia examined with raclopride-C11 and positron emission tomography","volume":"148","author":"Talvik","year":"2006","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2015.02.020_bb0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","article-title":"Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy","volume":"54","author":"Tziortzi","year":"2011","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.schres.2015.02.020_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4088\/JCP.08r04171","article-title":"Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms","volume":"70","author":"Uchida","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.02.020_bb0135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0969-8051(00)00132-3","article-title":"Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method","volume":"27","author":"Wilson","year":"2000","journal-title":"Nucl. Med. Biol."},{"issue":"3","key":"10.1016\/j.schres.2015.02.020_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004647-199703000-00010","article-title":"Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness","volume":"17","author":"Wong","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.schres.2015.02.020_bb0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00004647-199703000-00009","article-title":"Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging","volume":"17","author":"Wong","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:25:35Z","timestamp":1760297135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":29,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0920996415001255"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.02.020","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine D2\/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia\u2014A [11C]-raclopride PET study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}